Effects of paraquat on plasma glucose, cortisol, catecholamines, and insulin in the beagle.
Paraquat is known to produce hyperglycemia in rodents, although the mechanisms responsible for the hyperglycemic effect of paraquat are not clearly understood. In this study we report the effects of paraquat (25 mg/kg iv) on plasma glucose, cortisol, catecholamines, and insulin in dogs. Paraquat caused a significant increase in plasma glucose level at all times of measurement except at 0.5 hr following paraquat administration. The cortisol levels after paraquat treatment were increased to 133, 305, 279, 418, 517, 672, and 567% above zero time control at 0.5, 1.5, 3, 6, 12, and 24 hr, and at death time respectively. The catecholamines at these times were increased to 42, 17, 72, 118, 138, 226, and 435% above the control. In contrast to cortisol and catecholamines, the plasma insulin levels after paraquat treatment were significantly decreased at 3, 6, 12, and 24 hr. These hormonal observations can explain, at least in part, the observed hyperglycemia, since all promote hyperglycemic states. For example, cortisol is gluconeogenic, catecholamines are glycogenolytic, and lower insulin levels result in depressed peripheral glucose utilization.
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002395:Catecholamines / Q000097:blood; D004285:Dogs / Q000378:metabolism*; D005260:Female; D006854:Hydrocortisone / Q000097:blood; D006943:Hyperglycemia / Q000139:chemically induced; D007328:Insulin / Q000097:blood; D010269:Paraquat / Q000097:blood / Q000633:toxicity*; D013997:Time Factors
D001786:Blood Glucose; D002395:Catecholamines; D007328:Insulin; D010269:Paraquat; D006854:Hydrocortisone